Pfizer Arthritis Drug Meets Main Goals of Trial
Links shared publicly online about this topic
Pfizer arthritis drug meets main goals of trial | Reuters
reuters.com — “BOSTON (Reuters) - Pfizer Inc said on Friday that its experimental rheumatoid arthritis drug met the main goals of a late-stage clinical trial, a welcome boost for the world's largest drugmaker as it seeks” View full resource at reuters.com
Most Recently Shared on March 4, 2011 at 1:54 pm By:
Pfizer arthritis drug meets main goals of trial http://reut.rs/ii8xMi
UPDATE 4-Pfizer arthritis drug meets main goals of trial | Reuters
reuters.com — “* Pfizer's JAK-inhibitor RA drug meets goals of trial * Reduced signs and symptoms of rheumatoid arthritis * Drug improved physical function, disease remission (More analyst comment, updates share” View full resource at reuters.com
Most Recently Shared on March 5, 2011 at 6:40 pm By:
Lisa Richwine Health Communicator
Pfizer JAK-inhibitor arthritis drug meets main goals of trial http://reut.rs/fkMx9j
Pfizer arthritis drug meets main goals of trial | Reuters
reuters.com — “BOSTON (Reuters) - Pfizer Inc said on Friday that its experimental rheumatoid arthritis drug met the main goals of a late-stage clinical trial, a welcome boost for the world's largest drugmaker as it seeks” View full resource at reuters.com
Most Recently Shared on March 4, 2011 at 1:52 pm By:
@Pfizer #arthritis drug meets main goals of late stage trial. http://t.co/T2BPGpz #CHT_Health
Pfizer arthritis drug meets main goals of trial | Reuters
reuters.com — “BOSTON (Reuters) - Pfizer Inc said on Friday that its experimental rheumatoid arthritis drug met the main goals of a late-stage clinical trial, a welcome boost for the world's largest drugmaker as it seeks” View full resource at reuters.com
Most Recently Shared on March 4, 2011 at 2:29 pm By:
Bruce McLucas, MD Doctor, ObGyn Physician, Surgeon, and Physician
Pfizer arthritis drug meets main goals of trial http://ow.ly/1bC23k
Pfizer RA Drug Meets Goals of Trial, Company Optimistic for FDA Approval - AOL Health
aolhealth.com — “Pfizer Inc is hoping to release its experimental rheumatoid arthritis drug after successfully completing another stage of a clinical trial. The trial” View full resource at aolhealth.com
Most Recently Shared on March 7, 2011 at 10:00 pm By:
#Pfizer Inc is hoping to release its experimental rheumatoid #arthritis drug after completing another stage of a trial.http://aol.it/gUwxqT
UPDATE 1-Pfizer drug promising in mid-stage psoriasis study | Reuters
reuters.com — “* 197-patient study of tasocitinib * Also in late-stage for rheumatoid arthritis NEW YORK, Oct 7 (Reuters) - Pfizer Inc's experimental drug tasocitinib showed promise in a mid-stage clinical” View full resource at reuters.com
Most Recently Shared on October 8, 2010 at 10:43 pm By:
National Psoriasis Foundation Dermatology and Health Organization
RT @PsoResearch JAK inhibitor tasocitinib from @Pfizer shows promise in phase 2 #clinicaltrial for #psoriasis. http://tinyurl.com/23nk7xq
Pfizer ends late-stage lung-cancer study | Reuters
reuters.com — “NEW YORK (Reuters) - Pfizer Inc said on Tuesday it has ended a late-stage lung cancer study of its experimental drug figitumumab after an analysis showed it was unlikely to meet the main goal of improving” View full resource at reuters.com
Most Recently Shared on December 30, 2009 at 1:47 pm By:
Lisa Jarvis Science Enthusiast
Pfizer ends PhIII trial of figitumumab in lung cancer: http://bit.ly/8lTlsa
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Reuters Health
-
Lisa Richwine
FDA and pharmaceutical industry correspondent for Reuters
-
Wayne Oliver
Supports common-sense, private sector health reform versus a 2,700 page, top-down, heavy-handed approach. Advocate for civil justice reform, HIT and FDA reform.
Advertisement
